These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 28922553)
21. Synthesis and properties of the simplified nucleic acid glycol nucleic acid. Meggers E; Zhang L Acc Chem Res; 2010 Aug; 43(8):1092-102. PubMed ID: 20405911 [TBL] [Abstract][Full Text] [Related]
22. Building DNA nanostructures for molecular computation, templated assembly, and biological applications. Rangnekar A; LaBean TH Acc Chem Res; 2014 Jun; 47(6):1778-88. PubMed ID: 24720350 [TBL] [Abstract][Full Text] [Related]
23. Structural DNA nanotechnology: state of the art and future perspective. Zhang F; Nangreave J; Liu Y; Yan H J Am Chem Soc; 2014 Aug; 136(32):11198-211. PubMed ID: 25029570 [TBL] [Abstract][Full Text] [Related]
25. Nucleic acid nanoparticles (NANPs) as molecular tools to direct desirable and avoid undesirable immunological effects. Johnson MB; Chandler M; Afonin KA Adv Drug Deliv Rev; 2021 Jun; 173():427-438. PubMed ID: 33857556 [TBL] [Abstract][Full Text] [Related]
29. Design and Characterization of Compact, Programmable, Multistranded Nonimmunostimulatory Nucleic Acid Nanoparticles Suitable for Biomedical Applications. Brumett R; Danai L; Coffman A; Radwan Y; Teter M; Hayth H; Doe E; Pranger K; Thornburgh S; Dittmer A; Li Z; Kim TJ; Afonin KA; Khisamutdinov EF Biochemistry; 2024 Feb; 63(3):312-325. PubMed ID: 38271599 [TBL] [Abstract][Full Text] [Related]
30. Therapeutic immunomodulation by rationally designed nucleic acids and nucleic acid nanoparticles. Panigaj M; Skelly E; Beasock D; Marriott I; Johnson MB; Salotti J; Afonin KA Front Immunol; 2023; 14():1053550. PubMed ID: 36798121 [TBL] [Abstract][Full Text] [Related]
31. DNA Nanotechnology-Based Biosensors and Therapeutics. Shen L; Wang P; Ke Y Adv Healthc Mater; 2021 Aug; 10(15):e2002205. PubMed ID: 34085411 [TBL] [Abstract][Full Text] [Related]
32. Beyond DNA origami: the unfolding prospects of nucleic acid nanotechnology. Michelotti N; Johnson-Buck A; Manzo AJ; Walter NG Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(2):139-52. PubMed ID: 22131292 [TBL] [Abstract][Full Text] [Related]
33. Aptamers as Functional Modules for DNA Nanostructures. Shiu SC; Kinghorn AB; Guo W; Slaughter LS; Ji D; Mo X; Wang L; Tran NC; Kwok CK; Shum AHC; Tse ECM; Tanner JA Methods Mol Biol; 2023; 2639():301-337. PubMed ID: 37166724 [TBL] [Abstract][Full Text] [Related]
34. Controlled Organization of Inorganic Materials Using Biological Molecules for Activating Therapeutic Functionalities. Chandler M; Minevich B; Roark B; Viard M; Johnson MB; Rizvi MH; Deaton TA; Kozlov S; Panigaj M; Tracy JB; Yingling YG; Gang O; Afonin KA ACS Appl Mater Interfaces; 2021 Aug; 13(33):39030-39041. PubMed ID: 34402305 [TBL] [Abstract][Full Text] [Related]
35. Effects of nanoscale confinement on the functionality of nucleic acids: implications for nanomedicine. Castronovo M; Stopar A; Coral L; Redhu SK; Vidonis M; Kumar V; Ben FD; Grassi M; Nicholson AW Curr Med Chem; 2013; 20(28):3539-57. PubMed ID: 23862623 [TBL] [Abstract][Full Text] [Related]
36. Decoding the conformation-linked functional properties of nucleic acids by the use of computational tools. Iacovelli F; Falconi M FEBS J; 2015 Sep; 282(17):3298-310. PubMed ID: 25940731 [TBL] [Abstract][Full Text] [Related]
37. A cationic amphiphilic co-polymer as a carrier of nucleic acid nanoparticles (Nanps) for controlled gene silencing, immunostimulation, and biodistribution. Halman JR; Kim KT; Gwak SJ; Pace R; Johnson MB; Chandler MR; Rackley L; Viard M; Marriott I; Lee JS; Afonin KA Nanomedicine; 2020 Jan; 23():102094. PubMed ID: 31669854 [TBL] [Abstract][Full Text] [Related]